Cresco Labs Inc.

CNSX:CL Rapport sur les actions

Capitalisation boursière : CA$736.1m

Cresco Labs Bilan de santé

Santé financière contrôle des critères 3/6

Cresco Labs possède un total de capitaux propres de $365.4M et une dette totale de $424.9M, ce qui porte son ratio d'endettement à 116.3%. Son actif total et son passif total sont $1.4B et de $1.0B. L'EBIT de Cresco Labs est $117.3M ce qui fait que son ratio de couverture des intérêts 2.1. Elle dispose de liquidités et de placements à court terme de $153.3M.

Informations clés

116.3%

Ratio d'endettement

US$424.86m

Dette

Ratio de couverture des intérêts2.1x
Argent liquideUS$153.30m
Fonds propresUS$365.37m
Total du passifUS$1.02b
Total des actifsUS$1.38b

Mises à jour récentes de la santé financière

Recent updates

Getting In Cheap On Cresco Labs Inc. (CSE:CL) Is Unlikely

Oct 24
Getting In Cheap On Cresco Labs Inc. (CSE:CL) Is Unlikely

Cresco Labs Inc. (CSE:CL) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates

Aug 11
Cresco Labs Inc. (CSE:CL) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates

Are Investors Undervaluing Cresco Labs Inc. (CSE:CL) By 34%?

Jul 17
Are Investors Undervaluing Cresco Labs Inc. (CSE:CL) By 34%?

Here's Why Cresco Labs (CSE:CL) Has A Meaningful Debt Burden

Jun 19
Here's Why Cresco Labs (CSE:CL) Has A Meaningful Debt Burden

Cresco Labs Inc.'s (CSE:CL) 26% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

Jun 19
Cresco Labs Inc.'s (CSE:CL) 26% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

Cresco Labs Inc. (CSE:CL) Released Earnings Last Week And Analysts Lifted Their Price Target To CA$5.41

Mar 16
Cresco Labs Inc. (CSE:CL) Released Earnings Last Week And Analysts Lifted Their Price Target To CA$5.41

Investors Don't See Light At End Of Cresco Labs Inc.'s (CSE:CL) Tunnel And Push Stock Down 32%

Mar 03
Investors Don't See Light At End Of Cresco Labs Inc.'s (CSE:CL) Tunnel And Push Stock Down 32%

Cresco Labs (CSE:CL) Seems To Be Using A Lot Of Debt

Jan 26
Cresco Labs (CSE:CL) Seems To Be Using A Lot Of Debt

Risks To Shareholder Returns Are Elevated At These Prices For Cresco Labs Inc. (CSE:CL)

Jan 04
Risks To Shareholder Returns Are Elevated At These Prices For Cresco Labs Inc. (CSE:CL)

Is Cresco Labs (CSE:CL) Using Too Much Debt?

Sep 22
Is Cresco Labs (CSE:CL) Using Too Much Debt?

Some Confidence Is Lacking In Cresco Labs Inc. (CSE:CL) As Shares Slide 33%

Aug 11
Some Confidence Is Lacking In Cresco Labs Inc. (CSE:CL) As Shares Slide 33%

Cresco Labs (CSE:CL) Has A Somewhat Strained Balance Sheet

Jan 25
Cresco Labs (CSE:CL) Has A Somewhat Strained Balance Sheet

Are Investors Undervaluing Cresco Labs Inc. (CSE:CL) By 24%?

Dec 13
Are Investors Undervaluing Cresco Labs Inc. (CSE:CL) By 24%?

We Think Cresco Labs (CSE:CL) Is Taking Some Risk With Its Debt

Aug 22
We Think Cresco Labs (CSE:CL) Is Taking Some Risk With Its Debt

Estimating The Intrinsic Value Of Cresco Labs Inc. (CSE:CL)

May 23
Estimating The Intrinsic Value Of Cresco Labs Inc. (CSE:CL)

Analyse de la situation financière

Passif à court terme: Les actifs à court terme de CL ( $311.9M ) dépassent ses passifs à court terme ( $158.6M ).

Passif à long terme: Les actifs à court terme de CL ( $311.9M ) ne couvrent pas ses passifs à long terme ( $859.0M ).


Historique et analyse du ratio d'endettement

Niveau d'endettement: Le ratio dette nette/capitaux propres de CL ( 74.3% ) est considéré comme élevé.

Réduire la dette: Le ratio d'endettement de CL est passé de 0% à 116.3% au cours des 5 dernières années.


Bilan


Analyse des pistes de trésorerie

Pour les entreprises qui ont été en moyenne déficitaires dans le passé, nous évaluons si elles disposent d'au moins un an de trésorerie.

Piste de trésorerie stable: Bien que non rentable CL dispose d'une piste de trésorerie suffisante pour plus de 3 ans si elle maintient son niveau actuel de flux de trésorerie disponible positif.

Prévisions de trésorerie: CL n'est pas rentable mais dispose d'une marge de trésorerie suffisante pour plus de 3 ans, grâce à un flux de trésorerie disponible positif et en croissance de 30.1 % par an.


Découvrir des entreprises saines